Recruiting
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
NCT07318324
- Conditions
- Avutometinib, Endometrial, Phase IB, +1 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States